Not all CDK4&6 Inhibitors are the same

Introduction

Take This Event

We are delighted to invite you to our virtual mBConnect webinar on February 24th. We are connecting clinical breast cancer experts in a series of case presentations and discussions. This webinar is going to be interactive and engaging based on a discussion and a live Q&A (participants may send their questions live via the webinar platform). Our clinical experts are Dr. Giampaolo Bianchini, Dr. Hady Ghanem and Dr. Nitesh Rohatgi, while Dr. Ahmed Allehebi will moderate the session.

Objectives

1- Defining HR+ HER2- MBC patients with high risk factors
2- which CDK 4 & 6 inhibitor to select
3- Managing CDK 4 & 6 inhibitors AEs

See Registration Policies, Cancellations & Refunds